NCT00896675View on ClinicalTrials.gov

Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

CompletedOBSERVATIONAL
Enrollment

352

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2009

Conditions
Head and Neck Cancer
Interventions
OTHER

proteomic profiles

blood samples analysis

OTHER

proteomic profiles

blood samples analysis

Trial Locations (3)

37064

Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville

Vanderbilt-Ingram Cancer Center at Franklin, Nashville

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt-Ingram Cancer Center

OTHER

NCT00896675 - Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer | Biotech Hunter | Biotech Hunter